A Phase Iib Clinical Trial to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine (Nm283) in ... Grant uri icon

Overview

total award amount

  • 19342.49

direct costs

  • 15473.99

sponsor award id

  • Idenix Pharmaceutica

Background

Time

date/time interval

  • November 1, 2005 - October 28, 2008

Identity

DSR Number

  • 06011768
  • 06091766
  • 07013166
  • 07082455

PeopleSoft Contract Number

  • 00058695

local award id

  • 00058695